Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
AstraZeneca
Harvard Business School
Baxter
McKinsey

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

GRANIX Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: GRANIX
Patents:0
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for GRANIX
Recent Clinical Trials for GRANIX

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Northwestern UniversityPhase 2
Northwestern UniversityPhase 2/Phase 3
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityPhase 2

See all GRANIX clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Baxter
McKesson
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.